Anemia, a condition characterized by a deficiency of red blood cells or hemoglobin, is a prevalent issue in clinical practice. Its multifactorial etiology requires a thorough and systematic diagnostic approach to determine the underlying cause and appropriate treatment.
The initial evaluation of anemia should include a comprehensive medical history and physical examination. This will help identify any potential symptoms such as fatigue, pallor, or dyspnea, as well as any clinical signs such as jaundice or splenomegaly. Additionally, a complete blood count (CBC) should be obtained to assess the severity of the anemia and provide clues to its cause.
Classification of anemia based on the mean corpuscular volume (MCV) helps narrow down the differential diagnosis. Microcytic anemia suggests iron deficiency, thalassemia, or anemia of chronic disease. Normocytic anemia may indicate acute blood loss, hemolysis, or renal disease. Macrocytic anemia suggests vitamin B12 or folate deficiency, myelodysplastic syndrome, or alcohol abuse.
Further diagnostic testing should be guided by the initial evaluation and MCV classification. Iron studies, reticulocyte count, hemoglobin electrophoresis, vitamin B12 and folate levels, and bone marrow biopsy may be necessary depending on the suspected cause. It is essential to consider the patient's demographics, comorbidities, and potential exposure to toxins or medications that could contribute to anemia.
Unraveling the complexities of anemia requires a comprehensive diagnostic approach that integrates clinical evaluation with laboratory testing. By systematically classifying and investigating anemia, healthcare professionals can accurately diagnose the underlying cause and initiate appropriate treatment. This approach not only addresses the anemia itself but also potentially uncovers other significant health conditions that may otherwise remain undetected.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation